PROG

Progenity Stock Price

3.31
0.07 (2.16%)
Upgrade to Real-Time
Afterhours (Closed)
3.31

Low
2.04

52 Week Range

High
12.374

Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Progenity Inc PROG NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.07 2.16% 3.31 19:58:54
Open Price Low Price High Price Close Price Prev Close
3.20 3.11 3.40 3.37 3.24
Bid Price Ask Price Spread News
3.32 3.36 0.04 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
5,194 1,825,518 $ 3.25 $ 5,938,509 2,688,108 2.04 - 12.374
Last Trade Time Type Quantity Stock Price Currency
19:57:15 formt 1,455 $ 3.31 USD

Progenity Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 200.17M 60.47M 23.36M $ 74.31M $ - -8.71 -0.40
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 2.75M 26.40%

more financials information »

Progenity News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical PROG Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week3.053.402.813.161,596,2870.268.52%
1 Month2.403.68992.042.863,859,0050.9137.92%
3 Months4.715.132.042.881,602,983-1.40-29.72%
6 Months6.807.862.043.701,050,863-3.49-51.32%
1 Year11.9612.3742.044.20694,548-8.65-72.32%
3 Years15.1115.902.044.31697,673-11.80-78.09%
5 Years15.1115.902.044.31697,673-11.80-78.09%

Progenity Description

Progenity Inc is a biotechnology company. It is engaged in developing and commercializing molecular testing products as well as innovating in the field of precision medicine. It utilizes a multi-omics approach, combining genomics, epigenomics, proteomics, and metabolomics, to molecular testing products and to the development of a suite of investigational ingestible devices and drug and device combinations designed to provide precise diagnostic sampling and drug delivery solutions. The firm generates its revenue from molecular laboratory tests, principally from the sale of Innatal, Preparent, and pathology molecular testing. The company's operations are carried out in the United States.


Your Recent History
NASDAQ
PROG
Progenity
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.